Vet Med - Czech, 2008, 53(8):397-411 | DOI: 10.17221/1930-VETMED

Hyaluronic acid (hyaluronan): a review

J. Necas1, L. Bartosikova1, P. Brauner2, J. Kolar2
1 Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
2 Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic

Hyaluronic acid (HA) is a high molecular weight biopolysacharide, discovered in 1934, by Karl Meyer and his assistant, John Palmer in the vitreous of bovine eyes. Hyaluronic acid is a naturally occurring biopolymer, which has important biological functions in bacteria and higher animals including humans. It is found in most connective tissues and is particularly concentrated in synovial fluid, the vitreous fluid of the eye, umbilical cords and chicken combs. It is naturally synthesized by a class of integral membrane proteins called hyaluronan synthases, and degraded by a family of enzymes called hyaluronidases. This review describes metabolisms, different physiological and pathological functions, basic pharmacological properties, and the clinical use of hyaluronic acid.

Keywords: hyaluronic acid; metabolism; toxicity

Published: August 31, 2008  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Necas J, Bartosikova L, Brauner P, Kolar J. Hyaluronic acid (hyaluronan): a review. Vet Med-Czech. 2008;53(8):397-411. doi: 10.17221/1930-VETMED.
Download citation

References

  1. Akmal M., Singh A., Anand A., Kesani A., Aslam N., Goodship A., Bentley G. (2005): The effects of hyaluronic acid on articular chondrocytes. Journal of Bone and Joint Surgery - British volume, 8, 1143-1149. Go to original source... Go to PubMed...
  2. Amarnath L.P., Srinivas A., Ramamurthi A. (2006): In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials, 27, 1416-1424. Go to original source... Go to PubMed...
  3. Antonas K.N., Fraser J.R.E., Muirden K.D. (1973): Distribution of biologically labelled hyaluronic acid injected into joints. Annals of Rheumatic Diseases, 32, 103-111. Go to original source... Go to PubMed...
  4. Balazs E.A., Denlinger J.L. (1984): The role of hyaluronic acid in arthritis and its therapeutic use. In: Peyron J.G. (ed.): Osteoarthritis: Current Clinical and Fundamental Problems. Geigy, Basle Geigy. 165-174.
  5. Balazs E.A., Denlinger J.L (1989): Clinical uses of hyaluronan. Ciba Found Symposium, 143, 265-275. Go to original source... Go to PubMed...
  6. Balazs E.A., Laurent T.C., Jeanloz R.W. (1986): Nomenclature of hyaluronic acid. Biochemical Journal, 235, 903. Go to original source... Go to PubMed...
  7. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., Jackson D.G. (1999): LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. The Journal of Cell Biology, 4, 789-801. Go to original source... Go to PubMed...
  8. Barbucci R., Magnani A., Casolaro M., Marchettini N., Rosi C., Bosco M. (1995): Modification of hyaluronic acid by insertion of sulfate groups to obtain a heparinlike molecule. Part I. Characterization and behavior in aqueous solution towards H+ and Cu2+ ions. Gazzetta Chimica Italiana, 125, 169-180.
  9. Barbucci R., Lamponi S., Borzacchiello A., Ambrosio L., Fini M., Torricelli P., Giardino R. (2002): Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials, 23, 4503-4513. Go to original source... Go to PubMed...
  10. Ahrens T., Assmann V., Fieber C., Termeer C.C., Herrlich Bentsen K.D., Henriksen J.H., Boesby S., Horstev-PeP., Hofmann M., Simon J.C. (2001): CD44 is the principal mediator of hyaluronic-acid-induced melanoma tersen K., Lorenzen I. (1989): Hepatic and renal excretion of circulating type III procollagen amino-terminal cell proliferation. Journal of Investigative Dermatol- propeptide and hyaluronan in pig. Journal of Hepatology, 116, 93-101. ogy, 9, 177-183. Go to original source... Go to PubMed...
  11. Brown M.B., Jones S.A. (2005): Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. Journal of European Academy of Dermatology and Venereology, 19, 308-318. Go to original source... Go to PubMed...
  12. Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A. Jr., Kubalak S., Klewer S.E., McDonald J.A. (2000): Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. Journal of Clinical Investigation, 106, 349-360. Go to original source... Go to PubMed...
  13. Chen W.Y.J., Abatangelo G. (1999): Functions of hyaluronan in wound repair. Wound Repair and Regeneration, 7, 79-89. Go to original source... Go to PubMed...
  14. Cowman M.K., Matsuoka S. (2005): Experimental approaches to hyaluronan structure. Carbohydrate Research, 340, 791-809. Go to original source... Go to PubMed...
  15. Dechert T.A., Ducale A.E., Ward S.I., Yager D.R. (2006): Hyaluronan in human acute and chronic dermal wounds. Wound Repair and Regeneration, 14, 252-258. Go to original source... Go to PubMed...
  16. Ding M., Danielsen C.C., Hvid I. (2005): Effects of hyaluronan on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Bone, 36, 489-501. Go to original source... Go to PubMed...
  17. Echigo R., Mochizuki M., Nishimura R., Sasaki N. (2006): Suppressive effect of hyaluronan on chondrocyte apoptosis in experiment induced acute osteoarthritis in dog. Journal of Veterinary Medical Sciences, 68, 899-902. Go to original source... Go to PubMed...
  18. Forsberg N., Von Malmborg N., Madsen K., Rolfsen W., Gustafson S. (1994): Receptors for hyaluronan on corneal endotelial cells. Experimental Eye Research, 59, 689-696. Go to original source... Go to PubMed...
  19. Fraser J.R.E., Laurent T.C., Pertoft H., Baxter E. (1981): Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochemical Journal, 200, 415-424. Go to original source... Go to PubMed...
  20. Gerwin N., Hops C., Lucke A. (2006): Intraarticular drug delivery in osteoarthritis. Advanced Drug Delivery Reviews, 58, 226-242. Go to original source... Go to PubMed...
  21. Girish K.S., Kemparaju K. (2006): Inhibition of Naja naja venon hyaluronidase: Role in the management of poisonous bite. Life Sciences, 87, 1433-1440. Go to original source... Go to PubMed...
  22. Hajjaji H.E., Cole A.A., Manicourt D.H. (2005): Chondrocytes, synoviocytes and dermal fibroblasts all express PH-20, a hyaluronidase active at neutral pH. Arthritis Research and Therapy, 7, R756-R768. Go to original source... Go to PubMed...
  23. Hascall V.C., Majors A.K., de la Motte C.A., Evanko S.P., Wang A., Drazba J.A., Strong S.A., Wight T.N. (2004): Intracellular hyaluronan: a new frontier for inflammation? Biochimica and Biophysica Acta, 1673, 3-12. Go to original source... Go to PubMed...
  24. Hill A., McFarlane S., Johnston P.G., Waugh D.J.J. (2006): The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Letters, 237, 1-9. Go to original source... Go to PubMed...
  25. Iacob S., Knudson C.B. (2006): Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. The International Journal of Biochemistry and Cell Biology, 38, 123-133. Go to original source... Go to PubMed...
  26. Jansen K., van der Werff J.F.A., van Wachem P.B., Nicolai J.P.A., de Leij L.F.M.H., van Luyn M.J.A. (2004): A hyaluronan-based nerve guide: in vitro cytotoxicity, subcutaneous tissue reactions, and degradation in the rat. Biomaterials, 25, 483-489. Go to original source... Go to PubMed...
  27. Jaracz S., Chen J., Kuznetsova L.V., Ojima I. (2005): Recent advances in tumor-targeting anticancer drug conjugates. Bioorganic and Medicinal Chemistry, 13, 5043-5054. Go to original source... Go to PubMed...
  28. Kahmann J.D., O'Brien R., Werner J.M., Heinegard D., Ladbury J.E., Campbell I.D., Day A.J. (2000): Localization and characterization of the hyaluronan-binding site on the Link module from human TSG-6. Structure, 8, 763-774. Go to original source... Go to PubMed...
  29. Karjalainen J.M., Tammi R.H., Tammi M.I., Eskelinen M.J., Agren U.M., Parkkinen J.J., Alhava E.M., Kosma V.M. (2000): Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. American Journal of Pathology, 157, 957-965. Go to original source... Go to PubMed...
  30. Kim C.H., Lee B.J., Yoon J., Seo K.M., Lee J.W., Choi E.S., Hong J.J., Lee Y.S., Park J.H. (2001): Therapeutic effect of hyaluronic acid on experimental osteoarthrosis of ovine temporomandibular joint. Journal of Veterinary Medical Sciences, 63, 1083-1089. Go to original source... Go to PubMed...
  31. Kim E., Baba D., Kimura M., Yamashita M., Kashiwabara S., Baba T. (2005): Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proceedings of the National Academy of Sciences of the United States of America, 50, 18028-18033. Go to original source... Go to PubMed...
  32. Kosaki R., Watanabe K., Yamaguchi Y. (1999): Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Research, 59, 1141-1145.
  33. Kreil G. (1995): Hyaluronidases-A group of neglected enzymes. Protein Sciences, 4, 1666-1669. Go to original source... Go to PubMed...
  34. Laurent T.C. (1989): The biology of hyaluronan. In: Ciba Foundation Symposium 143. John Wiley and Sons, New York. 1-298.
  35. Laurent T.C., Fraser J.R.E. (1992): Hyaluronan. FASEB Journal, 6, 2397-2404. Go to original source...
  36. Laurent U.B.G., Reed R.K. (1991): Turnover of hyaluronan in the tissues. Advanced Drug Delivery Reviews, 7, 237-256. Go to original source...
  37. Leach J.B., Schmidt C.E. (2004): Hyaluronan. Encyclopedia of Biomaterials and Biomedical Engineering. Marcel Dekker, New York. 779-789.
  38. Lebel L. (1991): Clearance of hyaluronan from the circulation. Advanced Drug Delivery Reviews, 7, 221-235. Go to original source...
  39. Lee J.Y., Spicer A.P (2000): Hyaluronan: a multifunctional, megaDalton, stealth molecule. Current Opinion in Cell Biology, 12, 581-586. Go to original source... Go to PubMed...
  40. Lim Y.J., Sim W.S., Kim Y.Ch., Lee S.Ch., Choi Y.L. (2003): The neurotoxicity of epidural hyaluronic acid in rabbits: A light and electron microscopic examination. Anesthesia and Analgesia, 97, 1716-1720. Go to original source... Go to PubMed...
  41. Lin G., Stern R. (2001): Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Letters, 163, 95-101. Go to original source... Go to PubMed...
  42. Liu N., Gao F., Han Z., Xu X., Underhill Ch.B., Zhang L. (2001): Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Research, 61, 5207-5214.
  43. Lokeshwar V.B., Schroeder G.L., Carey R.I., Soloway M.S., Iida N. (2002): Regulation of hyaluronidase activity by alternative mRNA splicing. Journal of Biological Chemistry, 277, 33654-33663. Go to original source... Go to PubMed...
  44. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., Noble P.W. (1996): Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. Journal of Clinical Investigation, 98, 2403-2413. Go to original source... Go to PubMed...
  45. Medina J.M., Thomas A., Denegar C.R. (2006): Knee osteoarthritis: Should your patient opt for hyaluronic acid injection? Journal of Family Practice, 8, 667-675.
  46. Meyer K., Palmer J.W. (1934): The polysaccharide of the vitreous humor. Journal of Biology and Chemistry, 107, 629-634. Go to original source...
  47. Mio K., Stern R. (2002): Inhibitors of the hyaluronidases. Matrix Biology, 21, 31-37. Go to original source... Go to PubMed...
  48. Moreland L.W. (2003): Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Research and Therapy, 5, 54-67. Go to original source... Go to PubMed...
  49. Nawrat P., Surazynski A., Karna E., Palka J.A. (2005): The effect of hyaluronic acid on interleukin-1-induced deregulation of collagen metabolism in cultured human skin fibriblasts. Pharmacological Research, 51, 473-477. Go to original source... Go to PubMed...
  50. Neo H., Ishimaru J.I., Kurita K., Goss A.N. (1997): The effect of hyaluronic acid on experimental temporomandibular joint osteoarthrosis in the sheep. Journal of Oral Maxillofacial Surgery, 55, 1114-1119. Go to original source... Go to PubMed...
  51. Noble P.W. (2002): Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biology, 21, 25-29. Go to original source... Go to PubMed...
  52. Oertli B., Fan X., Wuthrich R.P. (1998): Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Nephrology Dialysis Transplantation, 13, 271-278. Go to original source... Go to PubMed...
  53. Paiva P., Van Damme M.P., Tellbach M., Jones R.L., Jobling T., Salamonsen L.A. (2005): Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecologic Oncology, 98, 193-202. Go to original source... Go to PubMed...
  54. Pohl M., Sakurai H., Stuart R.O., Nigam S.K. (2000): Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells. Developmental Biology, 224, 312-325. Go to original source... Go to PubMed...
  55. Ponnuraj K., Jedrzejas M. (2000): Mechanism of hyaluronan binding and degradation: Structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 Å resolution. Journal of Molecular Biology, 299, 885-895. Go to original source... Go to PubMed...
  56. Product information. Orthovisc®, Summary of safety and effectiveness data. 2004, 1-15.
  57. Protin U., Schweighoffer T., Jochum W., Hilberg F. (1999): CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets1. The Journal of Immunology, 163, 4917-4923. Go to original source... Go to PubMed...
  58. Pure E., Cuff C.A. (2001): A crucial role for CD44 in inflammation. Trends in Molecular Medicine, 7, 213-221. Go to original source... Go to PubMed...
  59. Roth A., Mollenhauer J., Wagner A., Fuhrmann R., Straub A., Venbrocks R.A., Petrow P., Brauer R., Schubert H., Ozegowski J., Peschel G., Muller P.J. (2005): Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis. Arthritis Research and Therapy, 7, 677-686. Go to original source... Go to PubMed...
  60. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J.L., Ohashi P.S., Paige C.J., Gutierrez-Ramos J.C., Mak T.W (1997): CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood, 90, 2217-2233. Go to original source...
  61. Smedsrod B. (1991): Cellular events in the uptake and degradation of hyaluronan. Advanced Drug Delivery Reviews, 7, 265-278. Go to original source...
  62. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. (2004): Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. Journal of Biological Chemistry, 279, 17079-17084. Go to original source... Go to PubMed...
  63. Toole B.P. (1997): Hyaluronan in morphogenesis. Journal of Internal Medicine, 242, 35-40. Go to original source... Go to PubMed...
  64. Toole B.P. (2001): Hyaluronan in morphogenesis. Cell and Developmental Biology, 12, 79-87. Go to original source... Go to PubMed...
  65. Toole B.P., Wight T.N., Tammi M.I. (2002): Hyaluronancell interactions in cancer and vascular disease. Journal of Biological Chemistry, 277, 4593-4596. Go to original source... Go to PubMed...
  66. Turley E.A., Noble P.W., W. Bourguignon L.Y. (2002): Signaling properties of hyaluronan receptors. Journal of Biological Chemistry, 277, 4589-4592. Go to original source... Go to PubMed...
  67. Tzircotis G., Thorne R.F., Isacke C.M. (2005): Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. Journal of Cell Science, 118, 5119-5128. Go to original source... Go to PubMed...
  68. Underhill C. (1992): CD44: The hyaluronan receptor. Journal of Cell Sciences, 103, 293-298. Go to original source... Go to PubMed...
  69. Uthman I., Raynauld J.P., Haraoui B. (2003): Intra-articular therapy in osteoarthritis. Postgradual Medicine Journal, 79, 449-453. Go to original source... Go to PubMed...
  70. Wang C.T., Lin J., Chang C.J., Lin Y.T., Hon S.M. (2004): Therapeutics effects of hyaluronic acid on osteoarthritis of the knee. The Journal of Bone and Joint Surgery - American Volume, 3, 538-545. Go to original source... Go to PubMed...
  71. Weigel J.A., Raymond R.C., Weigel P.H. (2002): The hyaluronan receptor for endicytosis (HARE) is not CD44 or CD54 (ICAM-1). Biochemical and Biophysical Research Communications, 294, 918-922. Go to original source... Go to PubMed...
  72. Wen D.Y. (2000): Intra-articular hyaluronic acid injections for knee osteoarthrosis. American Family Physician, 62, 565-570. Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.